Joshua M. Eizen - Chief Operating Officer and Chief Legal Officer at AN2 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer and Chief Legal Officer
Stock Symbol
ANTX on Nasdaq
All Insider Reports
All Insider Reports

Joshua M. Eizen - trading volume in the past year for AN2 Therapeutics, Inc.

Holdings reported by Joshua M. Eizen for AN2 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 175K $235K $1.34 Feb 26, 2025 Direct
Stock Option (right to buy) 117K Feb 26, 2025 Direct Common Stock

Transactions reported by Joshua M. Eizen for AN2 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.